Farther Finance Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-884
| Closed | -$117K | – | 4718 |
|
|
2025
Q1 | $117K | Buy |
884
+724
| +453% | +$95.5K | ﹤0.01% | 1459 |
|
|
2024
Q4 | $13.4K | Sell |
160
-15
| -9% | -$1.25K | ﹤0.01% | 2257 |
|
|
2024
Q3 | $12.8K | Buy |
175
+26
| +17% | +$1.9K | ﹤0.01% | 2263 |
|
|
2024
Q2 | $10.1K | Buy |
149
+57
| +62% | +$3.88K | ﹤0.01% | 2078 |
|
|
2024
Q1 | $6.28K | Sell |
92
-3
| -3% | -$205 | ﹤0.01% | 1961 |
|
|
2023
Q4 | $6.8K | Buy |
95
+85
| +850% | +$6.09K | ﹤0.01% | 1814 |
|
|
2023
Q3 | $521 | Sell |
10
-26
| -72% | -$1.36K | ﹤0.01% | 2257 |
|
|
2023
Q2 | $2.28K | Buy |
+36
| New | +$2.28K | ﹤0.01% | 1708 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$159 | – | 2450 |
|
|
2022
Q4 | $159 | Buy |
+3
| New | +$159 | ﹤0.01% | 2076 |
|